Search

everythinglearnresearchcommunity

for

Search:↓

The Drug Ontology was updated to better classify drugs for hypertension, malaria, and opioid abuse, and to allow for more accurate research queries.

Topical L-thyroxine may help with wound healing and hair growth but should be used short-term due to potential risks.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

The review found that women using hair loss drugs like finasteride and dutasteride rarely reported sexual side effects.

Old drugs can be used for new treatments, saving time and money, but there are challenges like needing more evidence and legal concerns.

Healthcare providers should start with simple fertility tests and treatments before referring patients to specialists.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Testosterone Replacement Therapy can improve sexual health in postmenopausal women with low sexual desire, but more research is needed on its long-term effects.

The document discusses a young boy with autism and early puberty but does not provide a conclusion on managing his behavior.

Testosterone replacement can help menopausal women with various symptoms, but should be used carefully and is not yet officially licensed in the UK for women.

Injecting steroids like Triamcinolone Acetonide for skin treatments can cause Cushing's Syndrome.

The best treatments for slowing down pattern hair loss are minoxidil and finasteride, with some other drugs and hair transplantation also used.

Lugol's solution can cause thyroid problems if used long-term for non-approved reasons.

The document concludes that women should not use 5-alpha-reductase inhibitors due to the risk of birth defects and limited effectiveness.

The conclusion is that effectively treating hair disorders is difficult due to the complex factors affecting hair growth and more research is needed to improve treatments.

Oral dutasteride is effective and safe for treating frontal fibrosing alopecia.

Deoxycholic acid is FDA-approved for reducing submental fat, but its mechanisms are not fully understood.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Rogaine can stop hair loss in women, and other treatments like certain pills, light therapy, and special shampoos may also work.

The paper suggests that France's suspension of Diane-35 was hasty and could cause treatment issues and unintended pregnancies, recommending a re-evaluation and better patient information.

Some drugs can cause serious side effects, like hypoglycemia from mix-ups, skin reactions, or depression, and while penicillamine may help rheumatoid arthritis more than auranofin, it has more severe side effects.

PRP and PRF show promise for hair growth but need more research for consistent and safe use.

Finasteride and minoxidil are approved treatments for hair loss, and hair transplants can be effective but require careful patient selection.

Avemor, a natural tonic made from aloe vera and moringa, was less effective than minoxidil in promoting hair growth on rabbits.

Patients with rheumatoid arthritis using tofacitinib had more serious side effects than those with alopecia areata.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.